The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition
Authors:
- Frederick NaftolinFNFrederick Naftolin
- Hugh S TaylorHTHugh S Taylor
- Richard KarasRKRichard Karas
- Eliot BrintonEBEliot Brinton
- Isadore NewmanINIsadore Newman
- Thomas B ClarksonTCThomas B Clarkson
- Michael MendelsohnMMMichael Mendelsohn
- Rogerio A LoboRLRogerio A Lobo
- Debra R JudelsonDJDebra R Judelson
- Lila E NachtigallLNLila E Nachtigall
- Christopher B HewardCHChristopher B Heward
- Harvey HechtHHHarvey Hecht
- 1 June 2004
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 81 (6) , 1498-1501
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Guidelines for the hormone treatment of women in the menopausal transition and beyondPosition statement by the Executive Committee of the International Menopause SocietyClimacteric, 2004
- Estrogen plus Progestin and the Risk of Coronary Heart DiseaseNew England Journal of Medicine, 2003
- Effects of Estrogen plus Progestin on Health-Related Quality of LifeNew England Journal of Medicine, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Estrogen replacement therapy, atherosclerosis, and vascular functionCardiovascular Research, 2002
- Rapid vascular cell responses to estrogen and membrane receptorsVascular Pharmacology, 2002
- Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study: A Prospective, Observational StudyAnnals of Internal Medicine, 2001
- Trends in the Incidence of Coronary Heart Disease and Changes in Diet and Lifestyle in WomenNew England Journal of Medicine, 2000
- Postmenopausal Estrogen Therapy and Cardiovascular DiseaseNew England Journal of Medicine, 1991
- 5 Management of osteoporosisBailliere's Clinical Endocrinology and Metabolism, 1988